First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
2019 ◽
Vol 47
(1)
◽
pp. 123-135
◽
2021 ◽
Vol 64
(2)
◽
pp. 909-924
◽
2013 ◽
Vol 54
(5)
◽
pp. 762-769
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4664-4664
◽